Data show biggest jump in global military spending since Cold War
European nations' collective spending increased by 17% to $693 billion amid the ongoing war in Ukraine, the organization's data show.
Russia's government increased its military spending by 38% to an estimated $149 billion last year, while Ukraine's grew by 2.9% to $64.7 billion. The Ukrainian spending amounted to 34% of the country's GDP, the largest military expenditure by percentage of GDP of any nation last year, according to SIPRI.
"Russia once again significantly increased its military spending, widening the spending gap with Ukraine," said Diego Lopes da Silva, a senior researcher at SIPRI. "Ukraine currently allocates all of its tax revenues to its military. In such a tight fiscal space, it will be challenging for Ukraine to keep increasing its military spending."
All NATO member nations increased their military spending, too, with 18 countries spending at least 2% of their GDP during 2024, which SIPRI said was the highest number of NATO members to hit that threshold since the alliance adopted it as a spending guideline in 2014.
"The rapid spending increases among European NATO members were driven mainly by the ongoing Russian threat and concerns about possible U.S. disengagement within the alliance," said Jade Guiberteau Ricard, another SIPRI researcher. "It is worth saying that boosting spending alone will not necessarily translate into significantly greater military capability or independence from the USA. Those are far more complex tasks."
In the Middle East, Israel and Lebanon significantly increased their military spending. Israel boosted its defense investment by 65% to $46.5 billion, while Lebanon increased its own by 58%, to $635 million.
"Despite widespread expectations that many Middle Eastern countries would increase their military spending in 2024, major rises were limited to Israel and Lebanon," said SIPRI researcher Zubaida Karim. "Elsewhere [in the region], countries either did not significantly increase spending in response to the war in Gaza or were prevented from doing so by economic constraints."
SIPRI said Iran's military expenditure fell in real terms by 10% to $7.9 billion, despite its involvement in regional conflicts.
U.S. military spending grew by 5.7% to $997 billion, amounting to 66% of NATO spending in 2024 and 37% of global military spending.
China was the world's second largest military spender last year behind the U.S., accounting for half of all military spending in Asia and Oceania, SIPRI said. China increased its spending by 7% to $314 billion.
"Major military spenders in the Asia-Pacific region are investing increasing resources into advanced military capabilities," said Nan Tian, the director of the SIPRI Military Expenditure and Arms Production Program. 'With several unresolved disputes and mounting tensions, these investments risk sending the region into a dangerous arms-race spiral."
Kristi Noem says she's "very confident" undocumented migrants stole her purse
Ashlie Crosson named 2025 National Teacher of the Year
Supreme Court appears poised to side with student with disability in school discrimination case
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Leading European Shipbuilder Selects Aino's SaaS Platform
Aino Health AB (publ) has signed an agreement with one of Europe's leading shipbuilding companies for the implementation of the Aino SaaS platform. The agreement covers 2,000 employees and aims to strengthen the customer's proactive work ability management and employee well-being initiatives. 'We are proud that our platform will support this organization in improving work ability and reducing health-related risks across their operations,' says Jyrki Eklund, CEO of Aino Health. Through the Aino platform, the customer will gain access to real-time data, automated early support processes, and root cause analysis tools – all designed to reduce sick leave and improve productivity. The implementation will begin during Q3 2025 with a phased rollout across production and administrative functions. The agreement aligns with Aino Health's strategic focus on the manufacturing industry and further strengthens the company's position in the European market. For more information Jyrki Eklund CEO Aino HealthPhone: +358 40 042 Certified adviser DNB Carnegie Investment Bank ABMore info: Aino Health (publ) Aino Health is the leading provider of Software as a Service (SaaS) solutions for Corporate health Management. Our comprehensive platform offers data-driven insights to enhance work ability, well-being and productivity, fostering high-performing organizations. By making health and wellness an integrated part of daily operations, we help reduce sickness absences, identify root causes of health challenges, and systematize proactive support for employees. For more information, please visit in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNBC
6 minutes ago
- CNBC
UBS CEO: Trump tariffs will impact consumption and inflation
UBS CEO Sergio Ermotti discusses the bank's better-than-expected quarterly results and the impact of U.S. President Donald Trump's tariffs on European exporters.
Yahoo
33 minutes ago
- Yahoo
3 European Stocks Estimated At Up To 41.3% Discount To Intrinsic Value
As European markets navigate the complexities of potential EU-U.S. trade deals and a slightly hawkish stance from the European Central Bank, investors are keenly observing opportunities that may arise from these developments. In this context, identifying stocks that are undervalued can be particularly appealing, as they offer potential value against a backdrop of cautious optimism in the market. Top 10 Undervalued Stocks Based On Cash Flows In Europe Name Current Price Fair Value (Est) Discount (Est) Talenom Oyj (HLSE:TNOM) €3.52 €6.95 49.3% Selvita (WSE:SLV) PLN35.50 PLN69.87 49.2% Logic Instrument (ENXTPA:ALLOG) €2.18 €4.32 49.5% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.75 €109.12 48.9% JOST Werke (XTRA:JST) €52.10 €102.82 49.3% Echo Investment (WSE:ECH) PLN5.36 PLN10.70 49.9% doValue (BIT:DOV) €2.548 €5.00 49% cyan (XTRA:CYR) €2.20 €4.36 49.5% BHG Group (OM:BHG) SEK24.50 SEK48.78 49.8% Atea (OB:ATEA) NOK143.60 NOK282.50 49.2% Click here to see the full list of 194 stocks from our Undervalued European Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Sartorius Stedim Biotech Overview: Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry globally, with a market cap of €17.47 billion. Operations: The company's revenue is primarily derived from its Biopharm segment, which generated €2.90 billion. Estimated Discount To Fair Value: 12.6% Sartorius Stedim Biotech's recent earnings report shows strong cash flow with a net income increase to €68.5 million for Q2 2025, up from €47.6 million the previous year. The stock trades at approximately 12.6% below its estimated fair value of €205.46 and is expected to see significant earnings growth of 27.49% per year, outpacing the French market average. Despite high debt levels, strategic expansions and partnerships bolster its long-term prospects in biopharmaceutical manufacturing. Upon reviewing our latest growth report, Sartorius Stedim Biotech's projected financial performance appears quite optimistic. Get an in-depth perspective on Sartorius Stedim Biotech's balance sheet by reading our health report here. Landis+Gyr Group Overview: Landis+Gyr Group AG, along with its subsidiaries, offers integrated energy management solutions to the utility sector across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions and has a market cap of CHF1.99 billion. Operations: The company's revenue is primarily derived from its operations in the Americas ($967.49 million), Europe, the Middle East, and Africa (EMEA) ($639.04 million), and the Asia Pacific region ($158.68 million). Estimated Discount To Fair Value: 18.3% Landis+Gyr Group's stock is trading at CHF69.2, approximately 18.3% below its estimated fair value of CHF84.73, suggesting potential undervaluation based on cash flows. The company's revenue is forecast to grow by 6.7% annually, surpassing the Swiss market average of 4%. Recent agreements with Withlacoochee River Electric Cooperative and advancements in smart grid technology may enhance future cash flows despite current profitability challenges and a recent net loss of US$150.46 million for fiscal year 2025. Our comprehensive growth report raises the possibility that Landis+Gyr Group is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Landis+Gyr Group. Overview: S.A. operates a leading commerce platform for consumers in Poland and internationally, with a market cap of PLN38.86 billion. Operations: generates revenue from its core commerce platform, serving consumers both in Poland and internationally. Estimated Discount To Fair Value: 41.3% is trading at PLN36.89, significantly below its estimated fair value of PLN62.85, indicating it may be undervalued based on cash flows. The company reported Q1 2025 sales of PLN2.62 billion and net income of PLN296.5 million, showing growth from the previous year. Earnings are projected to grow at 20.65% annually, outpacing the Polish market's average growth rate while revenue is expected to increase by 10.2% per year. The growth report we've compiled suggests that future prospects could be on the up. Click to explore a detailed breakdown of our findings in balance sheet health report. Summing It All Up Reveal the 194 hidden gems among our Undervalued European Stocks Based On Cash Flows screener with a single click here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:DIM SWX:LAND and WSE:ALE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data